Acquired
Novo Nordisk (Ozempic)
Ben Gilbert
So it turns out you actually don't need a deep pipeline if you have a drug that you can be profitable on, where there's not a lot of competitors for it. Your patent actually gives you a good amount of room. You build a brand around it. You get approved for a ton of indications that all have large populations. I mean, there is such a blockbuster that for a decade...
0
💬
0
Comments
Log in to comment.
There are no comments yet.